The Street 12/9/13
By: Adam Fuerstein
The Numbers Backing Gilead's Best and Fastest Drug Launch in History
BY Adam Feuerstein | 12/09/13 - 06:31 AM
Adam Feuerstein @adamfeuerstein 10m
My 2 cents: $GERN higher Mon/Tues on confirmed/solid bone marrow response + some evidence clinical benefit. No idea how much.
Geron to Host Analyst and Investor Meeting on December 9
Thomson Reuters ONE
Geron Corp. December 5, 2013 7:32 AM
Yahoo Finance 12/6/13
MENLO PARK, Calif., December 5, 2013 - Geron Corporation (GERN) today announced that management will be hosting a live webcast of an analyst and investor meeting at 6:30 p.m. CT on December 9, 2013.
As previously announced, data from the myelofibrosis IST will be presented by the study investigator, Dr.Ayalew Tefferi, Mayo Clinic, at ASH in a presentation entitled, "Imetelstat, a Telomerase Inhibitor, Induces Morphologic and Molecular Remissions in Myelofibrosis and Reversal of Bone Marrow Fibrosis".
The Street 12/5/13
Google : TSLA Getting Strong Orders From China
Wall Street Journal
Tesla’s Tumble Is a Buying Opportunity